Clinical Trials Directory

Trials / Conditions / Hypercalcemia

Hypercalcemia

30 registered clinical trials studyying Hypercalcemia — 5 currently recruiting.

StatusTrialSponsorPhase
Enrolling By InvitationCOR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Usi
NCT06763549
Peerbridge Health, Inc—
CompletedNear Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
NCT05152927
University of California, San FranciscoN/A
CompletedEvaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands Durin
NCT05022641
University of MichiganN/A
CompletedEvaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy
NCT04299425
Vanderbilt-Ingram Cancer CenterN/A
CompletedRate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum Electro
NCT04256369
King Faisal Specialist Hospital & Research Center—
RecruitingCalcitonin Pre-treatment to Improve SPECT-CT Sensitivity
NCT03935984
Joseph SferraPhase 4
RecruitingExploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of Paraffinoil
NCT04265599
Herlev Hospital—
RecruitingHypercalcemia After Paraffin Oil Injection
NCT04292288
Martin Blomberg Jensen—
WithdrawnPreoperational Fine Needle Aspiration of Pathological Parathyroid Gland
NCT03516747
HaEmek Medical Center, IsraelN/A
RecruitingRegistry for Hypoparathyroidism Wuerzburg
NCT05585593
University of Wuerzburg—
CompletedSearch for New Genetic Causes of Hypercalcemia by Massively Parallel Sequencing of a Genes Panel
NCT02908542
University Hospital, Caen—
WithdrawnInsulin Resistance in Primary Hyperparathyroidism
NCT02711059
Karolinska University HospitalN/A
UnknownParathyroid Hormone (PTH) Homeostasis in Bartter Syndrome
NCT01021280
Soroka University Medical Center—
TerminatedManagement of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol
NCT01725113
Winthrop University HospitalPhase 4
UnknownDifferentially Expressed Proteins in Sporadic Parathyroid Tumors
NCT01647503
Post Graduate Institute of Medical Education and Research, Chandigarh—
CompletedAn Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid
NCT01460030
Kyowa Kirin Co., Ltd.Phase 3
UnknownThe Novel Approach of Minimally Invasive Parathyroid Surgery Requires Precise Identification and Localization
NCT01226810
Rambam Health Care Campus—
WithdrawnPrimary Hyperparathyroidism (PHPT): Early Effect of Vitamin D
NCT01329666
Columbia UniversityPhase 2 / Phase 3
CompletedEfficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparat
NCT00975221
AmgenPhase 3
Active Not RecruitingCauses, Characteristics and Treatment of Hypercalcemia in the Emergency Room of a German Hospital
NCT06467877
University of Cologne—
CompletedEffectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Usin
NCT00891813
AbbottPhase 4
CompletedEffect of Vitamin D Treatment in Primary Hyperparathyroidism
NCT00674154
University of AarhusPhase 2 / Phase 3
CompletedArterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients
NCT00485706
Universitaire Ziekenhuizen KU LeuvenN/A
TerminatedCinacalcet to Treat Hypercalcemia in Renal Transplant Recipients
NCT00415584
Montefiore Medical CenterPhase 1 / Phase 2
CompletedCinacalcet to Treat Familial Primary Hyperparathyroidism
NCT00325104
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 3
CompletedStudy of 1.25 mmol/L Calcium Dialysate on Mineral Metabolism in Haemodialysis Patients.
NCT00744302
Sun Yat-sen UniversityPhase 2
CompletedDoes Treatment of Hypovitaminosis D Increase Calcium Absorption?
NCT00581828
University of Wisconsin, MadisonPhase 4
CompletedOral Peptones Load in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism and Healthy Subjects
NCT01042626
University of Eastern PiedmontN/A
CompletedZometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community
NCT00126386
Alberta Health servicesN/A
CompletedStudies of Elevated Parathyroid Activity
NCT00001277
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 2